BIOCEUTICAL PATENT PORTFOLIO FOR LUXEMBOURG BIOCEUTICAL INNOVATIONS

Description

WE HEREBY PUBLISH OUR BIOCEUTICAL PATENT PORTFOLIO THAT MAY PROVIDE EFFICIENT CURATIVE & PREVENTIVE MEANS FOR THE MOST SEEN MEDICAL AILMENTS IN LUXEMBOURG. OUR FORMULATIONS PORTFOLIO LISTED IN THIS DATASET INCLUDES BCL-2 EXPRESSION INHIBITORS, CYCLIN B1 & D2 INHIBITORS, Hıf-10 SUPPRESSIVE AGENTS, TNF-A & NF-KAPPA B COX-2 INTERLEUKIN-6 SUPPRESSIVE AND IMMUNOMODULATIVE AGENTS FOR AUTOIMMUNE DISEASES, FMO3 SUPPRESSIVE ANALGESIC AGENTS, THYROGENIC & THYROMODULATORY AGENTS, RNA POLYMERASE & DNA POLYMERASE & VIRAL DNA GYRASE SUPPRESSIVE ANTIVIRAL AGENTS, TOPOISOMERASE I & II, RIBONUCLEOTIDE REDUCTASE SUPPRESSIVE ANTIBACTERIAL AGENTS, GLUT4 TRANSLOCATIVE ANTIDIABETIC AGENTS AND MANY OTHER INNOVATIVE FORMULATIONS WITH NOVEL MECHANISMS OF ACTION.

WE HEREBY DISCLOSE OUR INVENTIONS FOR THE GREAT PEOPLE OF LUXEMBOURG IN ORDER TO PROVIDE AND EFFICIENT CONTRIBUTION TO THEIR COLLECTIVE HEALTH, AND FOR ALL.

BEST REGARDS

ERDAL CAN ALKOCLAR & METEHAN YESIL

Author

This dataset has been published on the initiative and under the responsibility of Erdal Can Alkoclar
Published on May 14, 2020 and updated on September 1, 2021

Latest update

May 17, 2020

License

Creative Commons Attribution 4.0

Metadata quality
56.0%

Update frequency not followed

File formats are closed

Temporal coverage not set

Spatial coverage not set

There are no reuses for this dataset yet.

Publish a reuse What's a reuse ?

There are no discussions for this dataset yet.

There are no community resources for this dataset yet.

Share your resources Learn more about the community